Fabricio Medina‐ Bolivar Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
grad_student
Research Areas
Biography and Research Information
OverviewAI-generated summary
Fabricio Medina-Bolivar's research investigates the potential anticancer mechanisms of natural compounds, specifically focusing on prenylated stilbenoids like arachidin-1. His work examines their efficacy as adjuvants for paclitaxel in treating triple-negative breast cancer cells.
Medina-Bolivar has contributed to the scientific community through publications in this area. His research network includes collaborations with Alexx Weaver at the University of Arkansas for Medical Sciences and Linh-Chi Ho at Arkansas State University. He also serves as a Co-Principal Investigator on a National Science Foundation grant that supported the acquisition of a 400 MHz Nuclear Magnetic Resonance (NMR) spectrometer for research at Arkansas State University, an award totaling $345,935.
Metrics
- Publications: 2
Selected Publications
-
Elucidating the Anticancer Mechanism of Arachidin‐1 in Triple‐Negative Breast Cancer Cells (2022)
-
Prenylated Stilbenoids as Potential Adjuvants for Paclitaxel in the Treatment of Triple‐Negative Breast Cancer (2022)
Federal Grants 1 $345,935 total
Collaboration Network
Top Collaborators
- Prenylated Stilbenoids as Potential Adjuvants for Paclitaxel in the Treatment of Triple‐Negative Breast Cancer
- Elucidating the Anticancer Mechanism of Arachidin‐1 in Triple‐Negative Breast Cancer Cells
- Prenylated Stilbenoids as Potential Adjuvants for Paclitaxel in the Treatment of Triple‐Negative Breast Cancer
- Elucidating the Anticancer Mechanism of Arachidin‐1 in Triple‐Negative Breast Cancer Cells
- Prenylated Stilbenoids as Potential Adjuvants for Paclitaxel in the Treatment of Triple‐Negative Breast Cancer
Similar Researchers
Based on overlapping research topics